Ketesse 25 mg Filmdragerad tablett Σουηδία - Σουηδικά - Läkemedelsverket (Medical Products Agency)

ketesse 25 mg filmdragerad tablett

menarini international operations luxembourg sa - dexketoprofentrometamol - filmdragerad tablett - 25 mg - propylenglykol hjälpämne; dexketoprofentrometamol 36,9 mg aktiv substans - dexketoprofen

Ketesse 50 mg/2 ml Injektions-/infusionsvätska, lösning Σουηδία - Σουηδικά - Läkemedelsverket (Medical Products Agency)

ketesse 50 mg/2 ml injektions-/infusionsvätska, lösning

menarini international operations luxembourg sa - dexketoprofentrometamol - injektions-/infusionsvätska, lösning - 50 mg/2 ml - dexketoprofentrometamol 36,9 mg aktiv substans; etanol, vattenfri hjälpämne - dexketoprofen

Dexmopet vet. 0,5 mg/ml Injektionsvätska, lösning Σουηδία - Σουηδικά - Läkemedelsverket (Medical Products Agency)

dexmopet vet. 0,5 mg/ml injektionsvätska, lösning

vetpharma animal health, s.l. - dexmedetomidinhydroklorid - injektionsvätska, lösning - 0,5 mg/ml - propylparahydroxibensoat hjälpämne; metylparahydroxibensoat hjälpämne; dexmedetomidinhydroklorid 0,5 mg aktiv substans - hund, katt

Dexofen 100 mg Tablett Σουηδία - Σουηδικά - Läkemedelsverket (Medical Products Agency)

dexofen 100 mg tablett

biophausia ab - dextropropoxifennapsilatmonohydrat - tablett - 100 mg - laktosmonohydrat hjälpämne; dextropropoxifennapsilatmonohydrat 100 mg aktiv substans - dextropropoxifen

Dexofen 50 mg Tablett Σουηδία - Σουηδικά - Läkemedelsverket (Medical Products Agency)

dexofen 50 mg tablett

biophausia ab - dextropropoxifennapsilatmonohydrat - tablett - 50 mg - laktosmonohydrat hjälpämne; dextropropoxifennapsilatmonohydrat 50 mg aktiv substans - dextropropoxifen

Thalidomide BMS (previously Thalidomide Celgene) Ευρωπαϊκή Ένωση - Σουηδικά - EMA (European Medicines Agency)

thalidomide bms (previously thalidomide celgene)

bristol-myers squibb pharma eeig - talidomid - multipelt myelom - immunsuppressiva - thalidomide bms in combination with melphalan and prednisone as first line treatment of patients with untreated multiple myeloma, aged >/= 65 years or ineligible for high dose chemotherapy. thalidomide bms is prescribed and dispensed according to the thalidomide celgene pregnancy prevention programme (see section 4.

Thalidomide Lipomed Ευρωπαϊκή Ένωση - Σουηδικά - EMA (European Medicines Agency)

thalidomide lipomed

lipomed gmbh - talidomid - multipelt myelom - immunsuppressiva - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy. thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.

Thalidomide Zentiva 50 mg Kapsel, hård Σουηδία - Σουηδικά - Läkemedelsverket (Medical Products Agency)

thalidomide zentiva 50 mg kapsel, hård

zentiva k.s. - talidomid - kapsel, hård - 50 mg - laktosmonohydrat hjälpämne; propylenglykol hjälpämne; talidomid 50 mg aktiv substans

Mifegyne 200 mg Tablett Σουηδία - Σουηδικά - Läkemedelsverket (Medical Products Agency)

mifegyne 200 mg tablett

exelgyn, paris - mifepriston - tablett - 200 mg - mifepriston 200 mg aktiv substans - mifepriston

Phosphoral 24,4 g/10,8 g Oral lösning Σουηδία - Σουηδικά - Läkemedelsverket (Medical Products Agency)

phosphoral 24,4 g/10,8 g oral lösning

casen recordati, s.l. - dinatriumfosfatdodekahydrat; natriumdivätefosfatdihydrat - oral lösning - 24,4 g/10,8 g - natriumdivätefosfatdihydrat 542 mg aktiv substans; glycerol hjälpämne; dinatriumfosfatdodekahydrat 240 mg aktiv substans; natriumbensoat hjälpämne - mineralsalter i kombination